Phase Ii trials: use of a clinical tumor panel and overview of current resources and studies
Muggia, F.M.; Rozencweig, M.; Chiuten, D.F.; Jensen-Akula, M.S.; Charles, L.M.; Kubota, T.T.; Bono, V.H.
Cancer Treatment Reports 64(1): 1-9
1980
ISSN/ISBN: 0361-5960 PMID: 6991100 Document Number: 161846
Document emailed within 1 workday
Related Documents
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69Trimble, E.L.; Schoenfeldt, M. 2004: Clinical trials referral source. Current randomized phase IIi trials in gynecologic cancer Oncology 18(13): 1642; 1645-1646
Edwards, M.S.; Levin, V.A.; Wilson, C.B. 1980: Brain tumor chemotherapy: an evaluation of agents in current use for phase Ii and IIi trials Cancer Treatment Reports 64(12): 1179-1205
Grem, J.L.; Hoth, D.F.; Hamilton, J.M.; King, S.A.; Leyland-Jones, B. 1987: Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acid Cancer Treatment Reports 71(12): 1249-1264
Bria, E.; Vanni, B.; Cuppone, F.; Calabretta, F.; Campanella, C.; Torsello, A.; Terzoli, E. 2004: Metastatic breast cancer: is global survival increase a realistic endpoint in phase III clinical trials? Studies on taxanes; studies on trastuzumab I Supplementi di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S65-S66
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Cheson, B.D.; Phillips, P.H.; Trimble, E. 1994: Clinical trials. Referral resource. Phase Ii Ovarian Cancer Trials Oncology 8(4): 73-74
Storb, R. 1994: Preparative regimens for patients with leukemias and severe aplastic anemia (overview): biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center Bone Marrow Transplantation 14(Suppl 4): S1-S3
Trimble, E.; Valmonte, C.M.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials in cervical cancer Oncology 14(7): 1045-1046; 1049-1050
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current clinical trials in multiple myeloma Oncology 18(2): 196-198; 203
Davis, T.; Schoenfeldt, M.; Chevalier, S.M. 2005: Clinical trials referral resource. Current clinical trials in myelodysplastic syndrome Oncology 19(8): 1035-1036; 1038
Jaoko, W.G.; Ogutu, H.; Wakasiaka, S.; Malogo, R.; Ndambuki, R.; Nyange, J.; Omosa-Manyonyi, G.; Fast, P.; Schmidt, C.; Verlinde, C.; Smith, C.; Bhatt, K.M.; Ndinya-Achola, J.; Anzala, O. 2009: Pregnancy rates among female participants in phase i and phase IIA AIDS vaccine clinical trials in Kenya East African Medical Journal 86(9): 430-434
Jaillon, P.; Dupuis, B. 1989: Prerequisites for phase i and phase Ii clinical trials of drugs Archives des Maladies du Coeur et des Vaisseaux 82(10): 1773-1776
Cheson, B.D.; Sznol, M.; Phillips, P.H. 1995: Clinical trials referral resource. Tumor vaccine clinical trials Oncology 9(10): 929; 931
Saxman, S.B.; Smiley, J.K.; Cheson, B.D. 1999: Clinical trials referral resource. Current trials in melanoma Oncology 13(9): 1239-1242
Keppler, B.K.; Heim, M.E.; Flechtner, H.; Wingen, F.; Pool, B.L. 1989: Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase i studies Arzneimittel-Forschung 39(6): 706-709
Larson, S.M. 1990: Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials Cancer research 50(3 Suppl): 892s-898s
Teehan, M. 1994: Guidelines for phase IV clinical trials. Joint Committee on Phase IV Clinical Trial Guidelines Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 39(10): 629-633